Our studies have demonstrated that a crucial factor in platelet biogenesis TPM4 (Pleines et al., 2017) is inhibited (FC-1.94, p < 0.001) in severe cases, thereby providing novel biological insight into COVID-19 severity. The gene discussed is TPM4; the disease is COVID-19.